. Author manuscript; available in PMC: 2018 Apr 11.

Published in final edited form as: AJNR Am J Neuroradiol. 2018 Feb 15;39(4):704–712. doi: 10.3174/ajnr.A5547

Table 1.

Subject demographics in the two HIV+ groups: Asymptomatic neurocognitive impairment (ANI), and symptomatic HIV associated neurocognitive disorder (HAND). N = number of patients in each group. Values given are means ± standard deviation.

	ANI	HAND	P-value
N	24	21	–
Age, years	59.6 ± 5.7	58.2 ± 5.0	0.378
Male, n (%)	17 (71%)	16 (76%)	0.764
Education, years	14.9 ± 3.0	14.0 ± 2.7	0.263
Race (% African American)	12 (50%)	13 (62%)	0.655
Duration of Infection (years)	19.9±9.0	19.2±9.4	0.790
CES-D	7.7 ± 6.8	11.0 ± 11.7	0.253
HART Est IQ^*	112.9 ± 12.8	103.7 ± 12.9	0.022
CD4 cell count (cells/mm³)	674 ± 281	676 ± 375	0.988
Plasma HIV RNA (Log₁₀ copies/ml)	1.6 ± 0.1	2.3 ± 1.4	0.569

CES-D =Center for Epidemiological Studies Depression Score; HART Est IQ= Hopkins Adult Reading Test Estimated IQ; Plasma HIV RNA only among those with detectable viral load (n=2 ANI and n=3 HAND).

Significant P<0.05